Conditions: Type 2 Diabetes Mellitus
Keywords: insulin resistance
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 71
Healthy volunteers: no

Brief summary:
The purpose of this study is to evaluate the safety and efficacy of Canagliflozin (TA-7284) in combination with GLP-1 analogue in patients with type 2 Diabetes for 52 weeks.

Detailed description:
This is an open-label study to evaluate the long-term safety and efficacy of Canagliflozin (TA-7284) in Japanese patients with type 2 diabetes mellitus, who are receiving treatment with GLP-1 analogue on diet and exercise and have inadequate glycemic control. The patients will receive TA-7284 100mg orally for 52 weeks.

Arms:
arm 1: None

Interventions: intervention 1: Canagliflozin (TA-7284) intervention 2: GLP-1 analogue
Intervention descriptions: intervention 1: The patients will receive Canagliflozin orally for 52 weeks intervention 2: None

Protocol document: